top of page

About Us

Curious Wellness Group is an independent health intelligence platform focused on the structural realities of modern wellness -- where prescriptions, supplements, and emerging compounds intersect.

This work is informed by research, cross-disciplinary analysis, and real-world observation of how people engage with plant-based practices in social and everyday contexts. 

The focus is not product promotion. 

It is interpretation.

Explore
Photoroom_20250527_111343.jpg

Alexandra Sienkiewicz

Health literacy is not a trend. It is a responsibility.

Alexandra Sienkiewicz is the founder of Curious Wellness Group — a strategic advisory and education platform focused on the intersection of plant medicine, pharmacology, and modern consumer behavior.

Her work is grounded in a simple observation: the wellness industry has grown faster than its literacy.

Consumers are stacking supplements, combining botanicals with prescriptions, navigating aging, managing chronic risk factors, and experimenting with nootropics — often without clear guidance on interaction, dosage, or long-term implications.

 

Brands are innovating rapidly, yet regulatory structures, safety communication, and pathway transparency frequently lag behind.

Curious Wellness Group was built to address that gap.

Explore

The Perspective Behind the Work

Alexandra’s interest in plant-based wellness did not begin in theory — it began in observation.

As the founder of Kava Social, one of New York’s early kava bars, she witnessed firsthand how consumers engage with plant-based alternatives in social environments. She observed behavior patterns, dosage misunderstandings, alcohol substitution trends, and the cultural friction between traditional plant use and modern commercialization.

That experience sparked a deeper inquiry:


What happens when ancient plants meet contemporary pharmacology?

Since then, her work has focused on understanding:

  • Drug–herb and supplement interactions

  • Polypharmacy in aging populations

  • Menopause and hormonal stacking

  • Regulatory gray zones in nutraceutical marketing

  • The gap between marketing claims and biological mechanisms

She later founded Pill + Plant, an interaction intelligence platform designed to bring clarity to modern supplementation and reduce preventable risk.

Why What Is Kava Exists

"What Is Kava" was not written to promote a plant. It was written to interrogate one.

After founding Kava Social in New York, Alexandra saw firsthand how quickly a traditional botanical could become misunderstood in a modern marketplace. Kava was alternately marketed as a miracle relaxant, dismissed as dangerous, romanticized as spiritual, or reduced to a trend.

Very few people were asking harder questions:

  • What does the pharmacology actually show?

  • Where did the liver toxicity narrative originate?

  • How does dosage, preparation, and cultural context alter risk?

  • What happens when a plant traditionally consumed ceremonially is commercialized into capsules and extracts?

  • What are the implications when consumers combine it with alcohol, SSRIs, or other supplements?

The book became an investigation into something larger than kava itself.

It became a study in what happens when plant medicine collides with modern pharmacology, fragmented regulation, influencer marketing, and rising polypharmacy.

Writing "What Is Kava" clarified a deeper truth:

The wellness industry does not suffer from a lack of products.
It suffers from a lack of interaction literacy.

That realization directly led to the formation of Curious Wellness Group and the development of Pill + Plant.

Kava was the entry point.


Interaction intelligence became the mission.

What Curious Wellness Group Does

Curious Wellness Group operates at the intersection of:
 

  • Botanical education

  • Interaction literacy

  • Regulatory awareness

  • Strategic brand advisory
     

The firm works with wellness brands, founders, and investors who understand that long-term trust is more valuable than short-term hype.
 

Rather than helping companies “sell more,” Alexandra focuses on helping them:

  • Identify biological risk exposure

  • Build transparent safety frameworks

  • Communicate responsibly

  • Prepare for regulatory scrutiny

  • Differentiate through education
     

In an era of rising polypharmacy and stacked supplementation, interaction literacy is no longer optional. It is infrastructure.

bottom of page